Outcomes | Timea | Groupa | Interaction | ||||||
---|---|---|---|---|---|---|---|---|---|
f | p-value | ηp2 | f | p-value | ηp2 | f | p-value | ηp2 | |
(1–13) | (1–13) | (1–13) | |||||||
Clinical measures | |||||||||
 FDS | 73.16 |  < 0.001 | 0.86 | 18.62 | 0.001 | 0.61 | 20.1 | 0.001 | 0.63 |
 SCWT | 14.1 | 0.003 | 0.54 | 0.29 | 0.603 | 0.02 | 0.42 | 0.531 | 0.03 |
 WR | 45.16 |  < 0.001 | 0.79 | 26.3 |  < 0.001 | 0.69 | 26.3 |  < 0.001 | 0.69 |
 NWR | 16.16 | 0.002 | 0.57 | 1.89 | 0.194 | 0.14 | 8.29 | 0.014 | 0.41 |
 PD | 56.34 |  < 0.001 | 0.82 | 0.9 | 0.37 | 0.07 | 17.12 | 0.001 | 0.59 |
 TC | 57.83 |  < 0.001 | 0.83 | 0.09 | 0.77 | 0.01 | 5.79 | 0.033 | 0.33 |
 CW | 22.54 |  < 0.001 | 0.65 | 1.19 | 0.296 | 0.09 | 10.07 | 0.008 | 0.46 |
CoP measures | |||||||||
 QO-L (cm) | 0.22 | 0.647 | 0.02 | 3.62 | 0.081 | 0.23 | 1.47 | 0.25 | 0.2 |
 QO-A (cm2) | 1.94 | 0.189 | 0.14 | 1.07 | 0.321 | 0.08 | 16.46 | 0.002 | 0.58 |
 QO-MV (cm/s) | 0.25 | 0.628 | 0.02 | 3.56 | 0.084 | 0.23 | 1.41 | 0.258 | 0.11 |
 QO-AP (SD) | 0.24 | 0.639 | 0.02 | 1.17 | 0.301 | 0.09 | 10.05 | 0.004 | 0.27 |
 QO-ML (SD) | 10.05 | 0.008 | 0.46 | 0.09 | 0.765 | 0.01 | 16.84 | 0.001 | 0.58 |
 QC-L (cm) | 1.9 | 0.195 | 0.14 | 0.78 | 0.396 | 0.06 | 0 | 0.993 | 0 |
 QC-A (cm2) | 0.22 | 0.644 | 0.02 | 0.38 | 0.551 | 0.03 | 1.8 | 0.204 | 0.13 |
 QC-MV (cm/s) | 2.36 | 0.151 | 0.16 | 0.93 | 0.353 | 0.07 | 0.03 | 0.864 | 0 |
 QC-AP (SD) | 0.03 | 0.866 | 0 | 0.08 | 0.783 | 0 | 6.27 | 0.028 | 0.34 |
 QC-ML (SD) | 2.23 | 0.161 | 0.16 | 0.08 | 0.782 | 0 | 0.03 | 0.861 | 0 |